Overview

Role of Propranolol as Compared to Bleomycin in Management of Hemangioma

Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
Infantile hemangiomas are widespread vascular tumours having incidence of 10% and most of them involute spontaneously. However, they are known to be located in proximity of vital organs and can have poor cosmetic and functional sequel if left untreated. A wide range of treatment options are available from expectant therapy to radical surgical excision. Propanolol has also been shown to be effective in treating infantile cutaneous hemangiomas. Similarly, anti-metabolite drugs as bleomycin has also shown promising results. Efficacy in terms of reduction in size of both treatments has been scarcely studied especially in Pakistan. OBJECTIVE: To assess the efficacy of oral propranolol and intraleisonal bleomycin in the treatment of infantile cutaneous hemangioma in terms of size regression
Phase:
N/A
Details
Lead Sponsor:
Shaheed Zulfiqar Ali Bhutto Medical University
Treatments:
Bleomycin
Propranolol